297 results on '"Morris, Patrick J."'
Search Results
2. Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search
3. High-potency ligands for DREADD imaging and activation in rodents and monkeys.
4. Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
5. Time will tell. Reply to “Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.” by Chen et al.
6. Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
7. 18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography
8. ( 2R,6R )-hydroxynorketamine exerts mGlu₂ receptor-dependent antidepressant actions
9. Antidepressant-relevant concentrations of the ketamine metabolite (2 R ,6 R )-hydroxynorketamine do not block NMDA receptor function
10. Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
11. Metabolic Profiling Reveals PAFAH1B3 as a Critical Driver of Breast Cancer Pathogenicity
12. Organophosphorus Flame Retardants Inhibit Specific Liver Carboxylesterases and Cause Serum Hypertriglyceridemia
13. Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma
14. EVALUATION OF BLOOD GAS VALUES IN ANESTHETIZED SOUTHERN WHITE RHINOCEROS ( CERATOTHERIUM SIMUM ) VENTILATED WITH A NOVEL DEMAND VENTILATOR IN A ZOOLOGICAL PARK SETTING
15. Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
16. Metabolic Profiling Reveals PAFAH1B3 as a Critical Driver of Breast Cancer Pathogenicity
17. NMDAR inhibition-independent antidepressant actions of ketamine metabolites
18. The show must go on. Reply to “Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al” by Insop Shim
19. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma
20. Repair of Horn and Frontal Bone Avulsion in a Forest Buffalo (Syncerus caffer nanus) with a Polymethylmethacrylate Dressing
21. Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2,6)- and (5R)-Methyl-(2R,6R)-hydroxynorketamines
22. Serum Gamma-Glutamyltransferase as a Prognostic Indicator of Neonatal Viability in Nondomestic Ruminants
23. Chemical Immobilization of Rhebok (Pelea capreolus) with Carfentanil-Xylazine or Etorphine-Xylazine
24. Osteomyelitis Associated with Salmonella enterica ss arizonae in a Colony of Ridgenose Rattlesnakes (Crotalus willardi)
25. A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801
26. Zanos et al. reply
27. Surgical Repair of an Atrial Septal Defect in a Juvenile Sumatran Orangutan (Pongo pygmaeus sumatraensis)
28. Medicine
29. Pharmacokinetics of Ticarcillin and Amikacin in Blue-Fronted Amazon Parrots (Amazona aestiva aestiva)
30. Vaccine-Induced Canine Distemper in European Mink, Mustela lutreola
31. Pharmacokinetic Properties of Itraconazole in Blue-Fronted Amazon Parrots (Amazona aestiva aestiva)
32. Determination of Sex in White-Throated Monitors (Varanus albigularis), Gila Monsters (Heloderma suspectum), and Beaded Lizards (H. horridum) Using Two-Dimensional Ultrasound Imaging
33. Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
34. Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
35. P199 - HILIC UPLC-MS/MS methods for the assessment of hydroxynorketamines pharmacokinetics in mouse plasma and brain
36. JOP812095_supplemental_material – Supplemental material for Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine
37. Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
38. ( R )‐Ketamine exerts antidepressant actions partly via conversion to ( 2R,6R )‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses
39. ( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
40. Injuries in cross-country skiing: trail markers for diagnosis and treatment
41. The show must go on. Reply to “Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al” by Insop Shim
42. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer
43. miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.
44. Chemical Immobilization of Felids, Ursids, and Small Ungulates
45. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine
46. miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential
47. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
48. Hemochromatosis in a Greater Indian Hill Mynah (Gracula religiosa): Case Report and Review of the Literature
49. Methacrylate Beak Prosthesis in a Marabou Stork (Leptoptilos crumeniferus)
50. Multiple Anesthetic Events in a Reticulated Giraffe (Giraffa camelopardalis)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.